Seizert Capital Partners LLC Buys 6,190 Shares of National Research Co. (NASDAQ:NRC)

Seizert Capital Partners LLC raised its stake in National Research Co. (NASDAQ:NRC) by 53.9% during the third quarter, HoldingsChannel reports. The institutional investor owned 17,668 shares of the company’s stock after acquiring an additional 6,190 shares during the period. Seizert Capital Partners LLC’s holdings in National Research were worth $404,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. CWM LLC grew its position in shares of National Research by 889.7% in the 2nd quarter. CWM LLC now owns 1,158 shares of the company’s stock valued at $27,000 after buying an additional 1,041 shares during the last quarter. Quarry LP bought a new stake in shares of National Research during the 2nd quarter valued at about $54,000. Benjamin F. Edwards & Company Inc. boosted its position in shares of National Research by 145.6% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,783 shares of the company’s stock valued at $64,000 after purchasing an additional 1,650 shares in the last quarter. SG Americas Securities LLC bought a new stake in shares of National Research during the 3rd quarter valued at about $124,000. Finally, Semanteon Capital Management LP bought a new stake in shares of National Research during the 3rd quarter valued at about $214,000. Institutional investors own 47.26% of the company’s stock.

National Research Stock Up 0.9 %

Shares of National Research stock opened at $19.14 on Monday. National Research Co. has a one year low of $17.62 and a one year high of $42.38. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.37. The stock’s 50-day moving average is $20.17 and its 200 day moving average is $23.52. The firm has a market cap of $456.87 million, a price-to-earnings ratio of 16.94 and a beta of 0.51.

National Research (NASDAQ:NRC) last announced its earnings results on Friday, October 25th. The company reported $0.24 EPS for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%. The company had revenue of $35.82 million for the quarter.

National Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $0.48 annualized dividend and a dividend yield of 2.51%. National Research’s payout ratio is 42.48%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.